Home Cart 0 Sign in  

[ CAS No. 77771-03-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 77771-03-0
Chemical Structure| 77771-03-0
Structure of 77771-03-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 77771-03-0 ]

Related Doc. of [ 77771-03-0 ]

Alternatived Products of [ 77771-03-0 ]

Product Details of [ 77771-03-0 ]

CAS No. :77771-03-0 MDL No. :MFCD00143093
Formula : C7H6BrFO Boiling Point : -
Linear Structure Formula :- InChI Key :HNVVROFWONXXGO-UHFFFAOYSA-N
M.W : 205.02 Pubchem ID :2773351
Synonyms :

Calculated chemistry of [ 77771-03-0 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 40.23
TPSA : 20.23 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.25 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.06
Log Po/w (XLOGP3) : 1.83
Log Po/w (WLOGP) : 2.35
Log Po/w (MLOGP) : 2.72
Log Po/w (SILICOS-IT) : 2.77
Consensus Log Po/w : 2.35

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.64
Solubility : 0.467 mg/ml ; 0.00228 mol/l
Class : Soluble
Log S (Ali) : -1.88
Solubility : 2.73 mg/ml ; 0.0133 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.36
Solubility : 0.0887 mg/ml ; 0.000433 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.44

Safety of [ 77771-03-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313 UN#:N/A
Hazard Statements:H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 77771-03-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 77771-03-0 ]
  • Downstream synthetic route of [ 77771-03-0 ]

[ 77771-03-0 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 77771-03-0 ]
  • [ 78239-71-1 ]
Reference: [1] Patent: US4792563, 1988, A,
[2] Patent: US4326087, 1982, A,
[3] Patent: WO2007/61670, 2007, A1, . Location in patent: Page/Page column 176-177
[4] Patent: WO2017/37146, 2017, A1, . Location in patent: Page/Page column 219; 220
  • 2
  • [ 77771-03-0 ]
  • [ 77771-02-9 ]
Reference: [1] Synthetic Communications, 2009, vol. 39, # 2, p. 366 - 370
[2] Patent: US4626601, 1986, A,
[3] Patent: US4626601, 1986, A,
[4] Patent: US4626601, 1986, A,
  • 3
  • [ 77771-03-0 ]
  • [ 74-88-4 ]
  • [ 887268-22-6 ]
YieldReaction ConditionsOperation in experiment
84%
Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 0.5 h;
Stage #2: at 0 - 20℃; for 1 h;
To a solution of (3-bromo-4-fluorophenyl)methanol (5.00 g, 24.4 mmol) in N,N-anhydrous N,N-dimethylformamide (50 mL) was added a 60percent suspension of sodium hydride in mineral oil (1.37 g, 34.2 mmol) in portions at 0° C., and the mixture was stirred at 0° C. for 30 minutes. To it was then added iodomethane (4.15 g, 29.3 mmol) at 0° C. The mixture was allowed to warm to ambient temperature and stirred for 1 h. The reaction was quenched by addition of water (200 mL) and extracted with ethyl acetate (3×200 mL). The combined organic layers were washed with brine (50 mL), dried over anhydrous sodium sulfate, and filtered. Concentration of the filtrate in vacuo and purification of the residue by column chromatography, eluting with 2 to 5percent of ethyl acetate in petroleum ether, afforded the title compound as a colorless oil (4.50 g, 84percent yield): 1H NMR (400 MHz, CDCl3) δ7.57 (dd, J=6.4, 2.0 Hz, 1H), 7.28-7.23 (m, 1H), 7.11 (t, J=8.0 Hz, 1H), 4.42 (s, 2H), 3.41 (s, 3H).
Reference: [1] Patent: US2018/162868, 2018, A1, . Location in patent: Paragraph 1534-1535
[2] Patent: US2004/220194, 2004, A1, . Location in patent: Page 23
[3] Patent: US2005/239795, 2005, A1, . Location in patent: Page/Page column 20
  • 4
  • [ 77771-03-0 ]
  • [ 887268-22-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 20, p. 7299 - 7317
  • 5
  • [ 77771-03-0 ]
  • [ 501420-63-9 ]
Reference: [1] Patent: WO2011/71565, 2011, A1,
[2] Patent: WO2010/93845, 2010, A1,
Same Skeleton Products
Historical Records